drugset / Trial / NCT05689177
Humoral Immunity Study After a Booster Dose of Soberana Plus (FINLAY-FR-1A) Vaccine Against COVID-19
Non-randomizedSingle-groupOpen-labelPrevention
Summary
To evaluate the dynamics of IgG levels to the SARS-CoV-2 virus after a booster dose of Soberana Plus vaccine.
Timeline
- Start
- 2022-12-09
- Primary completion
- 2023-03-10
- Completion
- 2023-07-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Soberana Plus | Vaccine | — | — |
Indications
No indication recorded.